Jeong, M.-S.; Lee, K.-W.; Choi, Y.-J.; Kim, Y.-G.; Hwang, H.-H.; Lee, S.-Y.; Jung, S.-E.; Park, S.-A.; Lee, J.-H.; Joo, Y.-J.;
et al. Synergistic Antitumor Activity of SH003 and Docetaxel via EGFR Signaling Inhibition in Non-Small Cell Lung Cancer. Int. J. Mol. Sci. 2021, 22, 8405.
https://doi.org/10.3390/ijms22168405
AMA Style
Jeong M-S, Lee K-W, Choi Y-J, Kim Y-G, Hwang H-H, Lee S-Y, Jung S-E, Park S-A, Lee J-H, Joo Y-J,
et al. Synergistic Antitumor Activity of SH003 and Docetaxel via EGFR Signaling Inhibition in Non-Small Cell Lung Cancer. International Journal of Molecular Sciences. 2021; 22(16):8405.
https://doi.org/10.3390/ijms22168405
Chicago/Turabian Style
Jeong, Mi-So, Kang-Wook Lee, Yu-Jeong Choi, Yun-Gyeong Kim, Hyun-Ha Hwang, Seo-Yeon Lee, Se-Eun Jung, Sun-Ah Park, Jin-Hee Lee, Yong-Joon Joo,
and et al. 2021. "Synergistic Antitumor Activity of SH003 and Docetaxel via EGFR Signaling Inhibition in Non-Small Cell Lung Cancer" International Journal of Molecular Sciences 22, no. 16: 8405.
https://doi.org/10.3390/ijms22168405
APA Style
Jeong, M.-S., Lee, K.-W., Choi, Y.-J., Kim, Y.-G., Hwang, H.-H., Lee, S.-Y., Jung, S.-E., Park, S.-A., Lee, J.-H., Joo, Y.-J., Cho, S.-G., & Ko, S.-G.
(2021). Synergistic Antitumor Activity of SH003 and Docetaxel via EGFR Signaling Inhibition in Non-Small Cell Lung Cancer. International Journal of Molecular Sciences, 22(16), 8405.
https://doi.org/10.3390/ijms22168405